Press releases - Ypsomed - United Kingdom

100 Years of Ypsotec

10/06/2016 - 07:00 Press Releases Ypsomed Group

Burgdorf – What began by establishing the Décolletage AG company 100 years ago and was continued from 1994 as a company within the Disetronic/Ypsomed Group is now Ypsotec: an internationally operating and successful vendor in the fields of precision engineering and medical technology with over 160 employees in Europe. Ypsotec AG will be celebrating its long and successful company history at a number of events.

Ypsomed 2015/16 business year: report and press release

20/05/2016 - 07:00 Press Releases Ypsomed Group

Burgdorf – In the business year 2015/16, the Ypsomed Group generated consolidated sales totaling CHF 336.9 million (prior year: CHF 306.6 million). Compared with the previous year, this represents an increase in sales of 9.9%. The operating results (EBIT) also increased by 55.7% compared to the previous year, from CHF 28.5 million to CHF 44.4 million and lies considerably above the expectations of CHF 41 million. As a result, the profitability at the EBIT level lies at 13.2% (prior year: 9.3%) – despite the present currency exchange situation. For the current business year 2016/17, Ypsomed expects an accelerated growth in sales of around 12% and an EBIT of approximately CHF 55 million.

Ypsomed expands the distribution of mylife OmniPod in Europe

24/02/2016 - 07:00 Press Releases Ypsomed Group

Burgdorf – From March 2016 the Ypsomed Group will be gradually introducing the tubing free insulin patch pump mylife OmniPod for distribution via existing Group companies also in France, Finland, Denmark, Ireland and Luxembourg. In so doing Ypsomed is taking a considerable step towards expanding the growth basis of its diabetes supply business.

Ypsomed to start supply of insulin pen developed on the YpsoPen platform to Ukraine

11/02/2016 - 07:00 Press Releases Ypsomed Group

Burgdorf – The reusable and affordable YpsoPen is becoming more and more popular. In the coming weeks, it will be supplied to Ukraine. The pharma company Indar, a private joint-stock company (PrJSC), is launching the insulin pen developed in Switzerland.

Ypsomed intensifies partnership with Tonghua Dongbao Pharmaceutical

05/01/2016 - 07:00 Press Releases Ypsomed Group

Burgdorf – Dongbao has been appointed the exclusive distributor for Ypsomed's mylife Clickfine pen needles in China.